Vaxart Inc (VXRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,220 | -18,645 | -18,007 | -9,582 | -29,400 |
| Depreciation Amortization | 2,710 | 3,596 | 3,221 | 548 | 100 |
| Accounts receivable | 3,285 | -1,823 | 13,500 | 960 | 100 |
| Accounts payable and accrued liabilities | 1,207 | -62 | -3,784 | -1,559 | N/A |
| Other Working Capital | 2,805 | 1,282 | 2,450 | -624 | -1,200 |
| Other Operating Activity | -1,537 | 2,562 | -11,928 | 217 | 400 |
| Operating Cash Flow | $-23,750 | $-13,090 | $-14,548 | $-10,040 | $-30,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,415 | 3,229 | -1,600 |
| PPE Investments | -1,220 | -850 | -707 | -47 | N/A |
| Net Acquisitions | N/A | N/A | 25,504 | N/A | N/A |
| Investing Cash Flow | $-1,220 | $-850 | $26,212 | $3,182 | $-1,600 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -3,799 | -1,528 | 0 | -400 |
| Common Stock Issued | 137,662 | 19,759 | 13 | 24 | N/A |
| Other Financing Activity | 652 | 0 | -214 | 0 | 0 |
| Financing Cash Flow | $138,314 | $15,960 | $-1,729 | $24 | $-400 |
| Beginning Cash Position | 13,526 | 11,506 | 1,571 | 8,405 | 49,700 |
| End Cash Position | 126,870 | 13,526 | 11,506 | 1,571 | 17,700 |
| Net Cash Flow | $113,344 | $2,020 | $9,935 | $-6,834 | $-32,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,750 | -13,090 | -14,548 | -10,040 | -30,000 |
| Capital Expenditure | -1,223 | -850 | -707 | -117 | N/A |
| Free Cash Flow | -24,973 | -13,940 | -15,255 | -10,157 | -30,000 |